On July 17, UnitedHealth rose 3.19% in regular trading, trading at $427.83/share, with turnover of $8.92 billion. The stock continued its post-earnings momentum as multiple Wall Street investment banks raised their price targets following the prior day's strong Q2 results.

On July 17, Morgan Stanley raised its target from $468 to $529, Bank of America from $475 to $512, Piper Sandler from $477 to $499, Cantor Fitzgerald from $440 to $495, and Jefferies from $401 to $490. The upgrades were driven by Q2 adjusted EPS of $6.38, which beat the consensus estimate of $4.86 by over 31%, alongside revenue of $112.03 billion exceeding the $110.8 billion estimate. The company also raised its full-year adjusted EPS guidance to $19.50-$20.00, significantly above the prior outlook of greater than $18.25 and the Street estimate of $18.49. Within the Managed Health Care sector, peer Humana rose 2.84% in sympathy.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)